Perpetual Ltd Purchases 493,408 Shares of Avantor, Inc. (NYSE:AVTR)

Perpetual Ltd grew its holdings in Avantor, Inc. (NYSE:AVTR) by 38.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,766,882 shares of the company’s stock after buying an additional 493,408 shares during the quarter. Perpetual Ltd’s holdings in Avantor were worth $37,228,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Envestnet Asset Management Inc. lifted its stake in shares of Avantor by 1.7% in the 2nd quarter. Envestnet Asset Management Inc. now owns 1,097,671 shares of the company’s stock valued at $23,271,000 after purchasing an additional 18,672 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Avantor by 8.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,434,195 shares of the company’s stock valued at $94,018,000 after buying an additional 350,247 shares during the period. Vanguard Personalized Indexing Management LLC lifted its holdings in Avantor by 4.6% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 25,440 shares of the company’s stock worth $539,000 after acquiring an additional 1,119 shares in the last quarter. Intech Investment Management LLC grew its stake in Avantor by 1.8% in the second quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock valued at $616,000 after acquiring an additional 514 shares during the period. Finally, Sei Investments Co. increased its holdings in shares of Avantor by 44.1% in the second quarter. Sei Investments Co. now owns 979,944 shares of the company’s stock worth $20,775,000 after acquiring an additional 300,125 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Stock Down 1.9 %

NYSE:AVTR opened at $22.14 on Tuesday. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00. The firm has a market capitalization of $15.07 billion, a price-to-earnings ratio of 48.13, a price-to-earnings-growth ratio of 3.51 and a beta of 1.28. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The stock’s 50 day moving average price is $21.45 and its two-hundred day moving average price is $23.39.

Analysts Set New Price Targets

AVTR has been the subject of several research analyst reports. Barclays decreased their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Wells Fargo & Company lowered their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. UBS Group restated a “neutral” rating and set a $25.00 price objective (down from $29.00) on shares of Avantor in a report on Friday. Robert W. Baird reduced their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, Avantor has an average rating of “Moderate Buy” and an average price target of $27.38.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.